Matthew Stanton
Stock Analyst at Jefferies
(0.05)
# 4,508
Out of 5,179 analysts
8
Total ratings
20%
Success rate
-34.05%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Maintains: Buy | $42 → $40 | $19.90 | +101.01% | 3 | Feb 4, 2026 | |
| RGEN Repligen | Maintains: Hold | $145 → $135 | $110.12 | +22.59% | 1 | Sep 12, 2025 | |
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $7.82 | +2.30% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $0.90 | +262.20% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $18.59 | +18.34% | 1 | Apr 4, 2024 |
Azenta
Feb 4, 2026
Maintains: Buy
Price Target: $42 → $40
Current: $19.90
Upside: +101.01%
Repligen
Sep 12, 2025
Maintains: Hold
Price Target: $145 → $135
Current: $110.12
Upside: +22.59%
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $7.82
Upside: +2.30%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $0.90
Upside: +262.20%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $18.59
Upside: +18.34%